Megakaryocytes co-localise with hemopoietic stem cells and release cytokines that up-regulate stem cell proliferation

Stem Cell Research

Volumn 11, Issue 2, 2013, Pages 782-792

  Heazlewood, Shen Y ^a   Neaves, Rebecca J ^b   Williams, Brenda ^a   Haylock, David N ^a,b   Adams, Timothy E ^a   Nilsson, Susan K ^a,b  

^a CSIRO   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CYTOKINE RELEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; PROGENY; UPREGULATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL GROWTH PROCESSES; CYTOKINES; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MEGAKARYOCYTES; MICE; MICE, INBRED C57BL; PROSPECTIVE STUDIES; UP-REGULATION;

EID: 84879490265     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.05.007     Document Type: Article

References (46)

1. Bartling B., Koch A., Simm A., Scheubel R., Silber R.E., Santos A.N. Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells. Int. J. Mol. Med. 2010, 25(1):89-96.
2. Baxter R.C. Insulin-like growth factor binding proteins in the human circulation: a review. Horm. Res. 1994, 42(4-5):140-144.
3. Beeton C.A., Bord S., Ireland D., Compston J.E. Osteoclast formation and bone resorption are inhibited by megakaryocytes. Bone 2006, 39(5):985-990.
4. Bord S., Frith E., Ireland D.C., Scott M.A., Craig J.I., Compston J.E. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. Bone 2005, 36(5):812-819.
5. Chan K., Spencer E.M. Megakaryocytes endocytose insulin-like growth factor (IGF) I and IGF-binding protein-3: a novel mechanism directing them into alpha granules of platelets. Endocrinology 1998, 139(2):559-565.
6. Ciovacco W.A., Cheng Y.H., Horowitz M.C., Kacena M.A. Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation. J. Cell. Biochem. 2010, 109(4):774-781.
7. Cohen P., Rajah R., Rosenbloom J., Herrick D.J. IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 278(3):L545-L551.
8. Conover C.A., Bale L.K., Durham S.K., Powell D.R. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. Endocrinology 2000, 141(9):3098-3103.
9. Dominici M., Rasini V., Bussolari R., et al. Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood 2009, 114(11):2333-2343.
10. Ellis S.L., Grassinger J., Jones A., et al. The relationship between bone, hemopoietic stem cells, and vasculature. Blood 2011, 118(6):1516-1524.
11. Erba E., Ubezio P., Broggini M., Ponti M., D'Incalci M. DNA damage, cytotoxic effect and cell-cycle perturbation of Hoechst 33342 on L1210 cells in vitro. Cytometry 1988, 9(1):1-6.
12. Fava R.A., Casey T.T., Wilcox J., Pelton R.W., Moses H.L., Nanney L.B. Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules. Blood 1990, 76(10):1946-1955.
13. Ferkowicz M.J., Starr M., Xie X., et al. CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo. Development 2003, 130(18):4393-4403.
14. Grassinger J., Haylock D.N., Storan M.J., et al. Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. Blood 2009, 114(1):49-59.
15. Grassinger J., Haylock D.N., Williams B., Olsen G.H., Nilsson S.K. Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biologic potential. Blood 2010, 116(17):3185-3196.
16. Grellier P., Yee D., Gonzalez M., Abboud S.L. Characterization of insulin-like growth factor binding proteins (IGFBP) and regulation of IGFBP-4 in bone marrow stromal cells. Br. J. Haematol. 1995, 90(2):249-257.
17. Guler H.P., Zapf J., Schmid C., Froesch E.R. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol. (Copenh) 1989, 121(6):753-758.
18. Haylock D.N., Williams B., Johnston H.M., et al. Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells 2007, 25(4):1062-1069.
19. Heazlewood S.Y., Williams B., Storan M.J., Nilsson S.K. The prospective isolation of viable, high ploidy megakaryocytes from adult murine bone marrow by fluorescence activated cell sorting. Stem Cell Niche: Methods and Protocols, Methods in Molecular Biology 2013, vol. 1035. Springer Science+Business Media LLC, USA.
20. Huynh H., Iizuka S., Kaba M., et al. Insulin-like growth factor-binding protein 2 secreted by a tumorigenic cell line supports ex vivo expansion of mouse hematopoietic stem cells. Stem Cells 2008, 26(6):1628-1635.
21. Huynh H., Zheng J., Umikawa M., et al. IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells. Blood 2011, 118(12):3236-3243.
22. Jennings L.K., Phillips D.R. Purification of glycoproteins IIb and III from human platelet plasma membranes and characterization of a calcium-dependent glycoprotein IIb-III complex. J. Biol. Chem. 1982, 257(17):10458-10466.
23. Jiang S., Levine J.D., Fu Y., et al. Cytokine production by primary bone marrow megakaryocytes. Blood 1994, 84(12):4151-4156.
24. Kacena M.A., Shivdasani R.A., Wilson K., et al. Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2. J. Bone Miner. Res. 2004, 19(4):652-660.
25. Kacena M.A., Nelson T., Clough M.E., et al. Megakaryocyte-mediated inhibition of osteoclast development. Bone 2006, 39(5):991-999.
26. Kansra S., Ewton D.Z., Wang J., Friedman E. IGFBP-3 mediates TGF beta 1 proliferative response in colon cancer cells. Int. J. Cancer 2000, 87(3):373-378.
27. Kirouac D.C., Ito C., Csaszar E., et al. Dynamic interaction networks in a hierarchically organized tissue. Mol. Syst. Biol. 2010, 6:417.
28. Kopp H.G., Hooper A.T., Broekman M.J., et al. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. J. Clin. Invest. 2006, 116(12):3277-3291.
29. Lemieux J.M., Horowitz M.C., Kacena M.A. Involvement of integrins alpha(3)beta(1) and alpha(5)beta(1) and glycoprotein IIb in megakaryocyte-induced osteoblast proliferation. J. Cell. Biochem. 2010, 109(5):927-932.
30. Liu L.Q., Sposato M., Liu H.Y., et al. Functional cloning of IGFBP-3 from human microvascular endothelial cells reveals its novel role in promoting proliferation of primitive CD34+CD38-hematopoietic cells in vitro. Oncol. Res. 2003, 13(6-10):359-371.
31. Martin J.L., Baxter R.C. Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3. Growth Factors 2011, 29(6):235-244.
32. Martin J.L., Lin M.Z., McGowan E.M., Baxter R.C. Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. J. Biol. Chem. 2009, 284(38):25542-25552.
33. Mohseni-Zadeh S., Binoux M. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action. Endocrinology 1997, 138(12):5645-5648.
34. Nakamura-Ishizu A., Okuno Y., Omatsu Y., et al. Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for hematopoietic regeneration. Blood 2012, 119(23):5429-5437.
35. Nilsson S.K., Dooner M.S., Tiarks C.Y., Weier H.U., Quesenberry P.J. Potential and distribution of transplanted hematopoietic stem cells in a nonablated mouse model. Blood 1997, 89(11):4013-4020.
36. Nilsson S.K., Haylock D.N., Johnston H.M., Occhiodoro T., Brown T.J., Simmons P.J. Hyaluronan is synthesized by primitive hemopoietic cells, participates in their lodgment at the endosteum following transplantation, and is involved in the regulation of their proliferation and differentiation in vitro. Blood 2003, 101(3):856-862.
37. Nilsson S.K., Johnston H.M., Whitty G.A., et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005, 106(4):1232-1239.
38. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4(1-2):7-25.
39. Shen Y., Nilsson S.K. Bone, microenvironment and hematopoiesis. Curr. Opin. Hematol. 2012, 19(4):250-255.
40. Smith L.H., Clayton M.L. Distribution of injected 59Fe in mice. Exp. Hematol. 1970, 20:82-86.
41. Stier S., Ko Y., Forkert R., et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 2005, 201(11):1781-1791.
42. Suzuki C., Okano A., Takatsuki F., et al. Continuous perfusion with interleukin 6 (IL-6) enhances production of hematopoietic stem cells (CFU-S). Biochem. Biophys. Res. Commun. 1989, 159(3):933-938.
43. Twigg S.M., Hardman K.V., Baxter R.C. A purified bovine serum albumin preparation contains an insulin-like growth factor (IGF) binding protein-3 fragment that forms ternary complexes selectively with IGF-II and the acid-labile subunit. Growth Horm. IGF Res. 2000, 10(4):215-223.
44. Wiezorek C. Cell cycle dependence of Hoechst 33342 dye cytotoxicity on sorted living cells. Histochemistry 1984, 81(5):493-495.
45. Winter O., Moser K., Mohr E., et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood 2010, 116(11):1867-1875.
46. Zhang C.C., Lodish H.F. Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. Blood 2004, 103(7):2513-2521.